Skip to main content

Monsanto Files A New Motion To Overrule The $2B Verdict

Monsanto Files A New Motion To Overrule The $2B Verdict

Monsanto Files A New Motion To Overrule The $2B Verdict

Introduction

According to Monsanto, repeated misconduct by plaintiffs’ counsel influenced jurors who awarded more than $2 billion to a couple in California in the trial over Roundup herbicide; now Monsanto seeks to overturn the May 13th verdict or to reduce the award.

Monsanto filed a motion for a new trial on Monday. According to the defendant's attorney, the verdict did not reflect as per the evidence presented in the case; it was based on inflammatory, fabricated, and irrelevant evidence from the plaintiffs' lawyer. The defendant has also raised other issues like the impact of pretrial publicity on jurors and due process concerns about the $2 billion punitive damages verdict; $1 billion each.

This was the third trial out of 13,400 pending lawsuits. U.S. District Judge Vince Chhabria overlooks the federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!